Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Medtronic
Baxter
Merck
Mallinckrodt

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

PROQUIN XR Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Proquin Xr patents expire, and what generic alternatives are available?

Proquin Xr is a drug marketed by Depomed Inc and is included in one NDA. There is one patent protecting this drug.

This drug has nineteen patent family members in fourteen countries.

The generic ingredient in PROQUIN XR is ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Sixty-one suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.

Drug patent expirations by year for PROQUIN XR
Recent Litigation for PROQUIN XR

Identify potential future generic entrants

District Court Litigation
Case NameDate
In re: Depomed, Inc.2015-12-30
Purdue Pharma L.P. v. Depomed, Inc.2015-09-15
Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.2015-09-15

See all PROQUIN XR litigation

PTAB Litigation
PetitionerDate
Endo Pharmaceutical Inc.2014-04-17
Purdue Pharma L.P.2014-01-24

See all PROQUIN XR litigation

Synonyms for PROQUIN XR
1-cyclopropyl-6-fluoranyl-4-oxidanylidene-7-piperazin-1-yl-quinoline-3-carboxylic acid hydrate hydrochloride
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid hydrochloride hydrate
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid hydrochloride monohydrate
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, monohydrochloride, monohydrate
1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid hydrate hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrate hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride--water (1/1)
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid hydrate hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid hydrate hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrate;hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-piperazinylhydroquinoline-3-carboxylic acid, ch loride, hydrate
128074-72-6
128074-75-9
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, monohydrochloride, hydrate
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, monohydrochloride, monohydrate
4BA73M5E37
86393-32-0
86483-48-9 (anhydr.)
93107-08-5 (anhydr.)
A841633
AC-7612
AC1L1Y6M
ACT02685
AK176012
AKOS005267156
Alcipro
AN-8828
API0009059
ARONIS24368
ARPUHYJMCVWYCZ-UHFFFAOYSA-N
AS-13483
Bay o 9867 monohydrate
Bay-o-9867 monohydrate
BBC/527
BC215763
BCP14053
Belmacina
C13993
C17H18FN3O3.ClH.H2O
C17H18FN3O3.HCl.H2O
Catex
CCG-220113
Cenin
Ceprimax
Cetraxal
CHEBI:59936
Ciflan
Ciflosin
Cilox
Ciloxan
Ciloxan (TN)
Cipad
Ciprenit
Cipro
Cipro (TN)
Cipro HC Otic Suspension
Cipro Inhale
Ciprocinal
Ciprofloxacin GR
Ciprofloxacin HCl Hydrochloride
Ciprofloxacin HCl monohydrate
Ciprofloxacin HCl, Pharmaceutical Secondary Standard; Certified Reference Material
Ciprofloxacin hydrochloride (USP)
Ciprofloxacin hydrochloride [USAN:JAN]
Ciprofloxacin hydrochloride [USAN:USP:JAN]
Ciprofloxacin hydrochloride for peak identification, European Pharmacopoeia (EP) Reference Standard
Ciprofloxacin hydrochloride hydrate
Ciprofloxacin hydrochloride hydrate (1:1:1)
Ciprofloxacin hydrochloride hydrate (JP17)
Ciprofloxacin hydrochloride hydrate, 98%
Ciprofloxacin hydrochloride monohydrate
Ciprofloxacin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Ciprofloxacin hydrochloride, United States Pharmacopeia (USP) Reference Standard
Ciprofloxacin monohydrochloride
ciprofloxacin monohydrochloride monohydrate
Ciprofur
Ciproktan
Cipronex
Cipropol
Ciproxin
Citeral
Cunesin
Cyproxan
D02216
DF-289
Disfabac
DRG-0110
DTXSID00273974
Felixene
Flociprin
Floxacipron
Flunas
FT-0602945
GA2367
Globuce
I06-0113
I06-113
I425
Inkamil
J10160
Keefloxin
KS-00000T79
Loxacid
LS-177929
Lypro
Megaflox
MFCD00242856
Microgan
MolPort-005-938-300
NCGC00180981-01
Nixin
Novidat
Novoquin
Ofitin
Oftacilox
Ophaflox
Phaproxin
Piprol
Plenolyt
Proquin
Proquin XR (TN)
Proxacin
Quinoflox
Quipro
Renator
Roflazin
RX710
Sarf
SBB080782
SCHEMBL27004
Sepcen
Septocipro
Siprogut
Sophixin
ST24037973
ST51039049
Strox
Suiflox
Supraflox
UNII-4BA73M5E37
Uritent
Utiminx
Velmonit
ZX-AS004730

US Patents and Regulatory Information for PROQUIN XR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 DISCN No No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PROQUIN XR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005   Start Trial   Start Trial
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005   Start Trial   Start Trial
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for PROQUIN XR

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1429780 122012000070 Germany   Start Trial PRODUCT NAME: KOMBINATION AUS CIPROFLOXACIN UND DEXAMETHASON, INSBESONDERE CIPROFLOXACINHYDROCHLORID UND DEXAMETHASON; NAT. REGISTRATION NO/DATE: 85150.00. 00 20120830; FIRST REGISTRATION: DAENEMARK 48976 20120808
1429780 SPC/GB12/058 United Kingdom   Start Trial PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
1429780 13C0012 France   Start Trial PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Dow
Medtronic
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.